Related Experiment Video

Updated: Jul 2, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Loss of Drop1 expression already at early tumor stages in a wide range of human carcinomas

Alexander Marmé1, Hans-Peter Zimmermann, Gerhard Moldenhauer

  • 1Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.

International Journal of Cancer
|August 19, 2008
PubMed

Insights

A study found the Drop1 protein mRNA significantly downregulated in most ovarian and mammary carcinomas. This deficiency is common across many cancer types, suggesting a role in malignant progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gene deregulation is a hallmark of cancer.
  • The SYNE1 gene's 5' region encodes the Drop1 protein.
  • Understanding gene expression changes is crucial for cancer research.

Purpose of the Study:

  • To investigate the role of Drop1 mRNA and protein in various carcinomas.
  • To determine the frequency and stage of Drop1 downregulation in epithelial tumors.

Main Methods:

  • Quantitative analysis of mRNA levels using cDNA arrays.
  • Immunohistochemical staining for Drop1 protein.
  • In situ hybridization to confirm mRNA expression patterns.
  • Two-hybrid studies to explore protein interactions.

Main Results:

  • Drop1 mRNA was downregulated 20- to 180-fold in most ovarian and mammary carcinomas.
  • Loss of Drop1 mRNA was confirmed in uterus, cervix, kidney, lung, thyroid, and pancreas carcinomas.
  • Downregulation occurred at early tumor stages and in all metastases.
  • Immunohistochemistry confirmed protein levels mirrored mRNA expression.

Conclusions:

  • Drastic loss of Drop1 mRNA is a common feature in many epithelial carcinomas.
  • Drop1 deficiency may play a role in the malignant progression of epithelial tumors.
  • Further research into Drop1's function in cancer is warranted.

More Related Videos

Establishment and Analysis of Tumor Slice Explants As a Prerequisite for Diagnostic Testing11:00

Establishment and Analysis of Tumor Slice Explants As a Prerequisite for Diagnostic Testing

Published on: November 29, 2018

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...